Application | Comment | Organism |
---|---|---|
drug development | the vitamin D3 derivatives produced by the action of P450scc are good candidates for use in the therapy of hyperproliferative disorders | Bos taurus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Bos taurus | 5739 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Bos taurus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Bos taurus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
adrenal cortex | - |
Bos taurus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
20,23-dihydroxyvitamin D3 + reduced adrenodoxin + O2 | - |
Bos taurus | 17alpha,20,23-trihydroxyvitamin D3 + oxidized adrenodoxin + H2O | - |
? | |
20-hydroxyvitamin D3 + reduced adrenodoxin + O2 | - |
Bos taurus | 20,23-dihydroxyvitamin D3 + 17alpha,20,23-trihydroxyvitamin D3 + oxidized adrenodoxin + H2O | - |
? | |
vitamin D3 + reduced adrenodoxin + O2 | - |
Bos taurus | 20-hydroxyvitamin D3 + oxidized adrenodoxin + H2O | when incubated in 0.45% cyclodextrin, 20-hydroxyvitamin D3 is the major product of vitamin D3 metabolism by P450scc. The second major product is 20,23-dihydroxyvitamin D3. Major products dissociate from the P450scc active site and accumulate at a concentration well above the P450scc concentration | ? |
Synonyms | Comment | Organism |
---|---|---|
CYP11A1 | - |
Bos taurus |
cytochrome P450scc | - |
Bos taurus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
adrenodoxin | - |
Bos taurus |